Switch from protective to adverse inflammation during influenza: Viral determinants and hemostasis are caught as culprits

Cellular and Molecular Life Sciences

Volumn 71, Issue 5, 2014, Pages 885-898

  Berri, Fatma ^a   Lê, Vuong Ba ^a   Jandrot Perrus, Martine ^b,c,d   Lina, Bruno ^a   Riteau, Béatrice ^a,e  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICHAT HOSPITAL   (France)

^e CEMAGREF   (France)

Author keywords

Fibrinolysis; Hemostasis; HLA G; Inflammation; Influenza virus; Innate immune sensors; PAR1; Plasminogen

Indexed keywords

HEMOSTASIS; HLA-G ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC SURVEILLANCE; INFLAMMATION; INFLUENZA, HUMAN; MODELS, IMMUNOLOGICAL; RECEPTOR, PAR-1; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

EID: 84893848470     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1479-x     Document Type: Review

References (126)

1. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF (2012) Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2(3):276-286
2. Horimoto T, Kawaoka Y (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3(8):591-600
3. Palese P, Shaw ML (2007) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, vol 2, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1647-1689
4. Lamb R A K R (2001) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, pp 1487-1531
5. Moules V, Terrier O, Yver M, Riteau B, Moriscot C, Ferraris O, Julien T, Giudice E, Rolland JP, Erny A, Bouscambert-Duchamp M, Frobert E, Rosa-Calatrava M, Pu Lin Y, Hay A, Thomas D, Schoehn G, Lina B (2011) Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology 414(1):51-62
6. Le Bouder F, Morello E, Rimmelzwaan GF, Bosse F, Pechoux C, Delmas B, Riteau B (2008) Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol 82(14):6820-6828
7. Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P (2008) Cellular proteins in influenza virus particles. PLoS Pathog 4(6):e1000085
8. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368(20):1888-1897
9. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, De Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336(6088):1534-1541
10. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403):420-428
11. De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Hado Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12(10):1203-1207
12. Ichinohe T (2010) Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design. Expert Rev Vaccines 9(11):1315-1324
13. Garcia-Sastre A (2011) Induction and evasion of type I interferon responses by influenza viruses. Virus Res 162 (1-2):12-18
14. Pascale F, Contreras V, Bonneau M, Courbet A, Chilmonczyk S, Bevilacqua C, Epardaud M, Niborski V, Riffault S, Balazuc AM, Foulon E, Guzylack-Piriou L, Riteau B, Hope J, Bertho N, Charley B, Schwartz-Cornil I (2008) Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol 180(9):5963-5972
15. La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85(2):85-92
16. Shinya K, Ito M, Makino A, Tanaka M, Miyake K, Eisfeld AJ, Kawaoka Y (2012) The TLR4-TRIF pathway protects against H5N1 influenza virus infection. J Virol 86(1):19-24
17. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, Van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133(2):235-249
18. Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J, Chen WH, Ernst RK, Rossignol DP, Gusovsky F, Blanco JC, Vogel SN (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497(7450):498-502. doi:10.1038/nature12118
19. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA (2004) Recognition of singlestranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101(15):5598-5603
20. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis E Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303(5663):1529-1531
21. Geeraedts F, Goutagny N, Hornung V, Severa M, De Haan A, Pool J, Wilschut J, Fitzgerald KA, Huckriede A (2008) Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog 4(8):e1000138
22. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M (2006) Detrimental contribution of the Toll-like receptor (TLR) 3 to influenza A virusinduced acute pneumonia. PLoS Pathog 2(6):e53
23. Zhao J, Wohlford-Lenane C, Zhao J, Fleming E, Lane TE, McCray PB Jr, Perlman S (2012) Intranasal treatment with poly (I*C) protects aged mice from lethal respiratory virus infections. J Virol 86(21):11416-11424
24. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E, Reis E Sousa C (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140(3):397-408
25. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis E Sousa C, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441(7089):101-105
26. Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T, Hornung V (2011) Inflammasomes: current understanding and open questions. Cell Mol Life Sci 68(5):765-783
27. Netea MG, Simon A, Van De Veerdonk F, Kullberg BJ, Van Der Meer JW, Joosten LA (2010) IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 6(2):e1000661
28. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206(1):79-87
29. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-Te Kippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30(4):556-565
30. Pothlichet J, Meunier I, Davis BK, Ting JP, Skamene E, Von Messling V, Vidal SM (2013) Type I IFN triggers RIGI/TLR3/NLRP3-dependent inflammasome activation in influenza A virus-infected cells. PLoS Pathog 9(4):e1003256
31. Van Riel D, Leijten LM, Van Der Eerden M, Hoogsteden HC, Boven LA, Lambrecht BN, Osterhaus AD, Kuiken T (2011) Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog 7(6):e1002099
32. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79(23):14933-14944
33. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, Reading PC (2009) Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 183(11):7441-7450
34. Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y (2007) Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 178(4):2448-2457
35. Peake J, Suzuki K (2004) Neutrophil activation, antioxidant supplements and exercise-induced oxidative stress. Exerc Immunol Rev 10:129-141
36. Hemmers S, Teijaro JR, Arandjelovic S, Mowen KA (2011) PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE 6(7):e22043
37. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, Van Rooijen N, Chow VT (2011) Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179(1):199-210
38. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4(8):e1000115
39. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, Van Rooijen N, Guan Y, Seo SH (2008) Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol 82(9):4265-4274
40. Ennis FA, Meager A, Beare AS, Qi YH, Riley D, Schwarz G, Schild GC, Rook AH (1981) Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 2(8252):891-893
41. Bryceson YT, Long EO (2008) Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 20(3):344-352
42. Riteau B, Barber DF, Long EO (2003) Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 198(3):469-474
43. Thielens A, Vivier E, Romagne F (2012) NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol 24(2):239-245
44. Orr MT, Lanier LL (2010) Natural killer cell education and tolerance. Cell 142(6):847-856
45. Achdout H, Manaster I, Mandelboim O (2008) Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J Virol 82(16):8030-8037
46. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, Keskinen P, Julkunen I (1997) Regulation of IFN-alpha/beta, MxA, 2', 5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J Immunol 158(5):2363-2374
47. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409(6823):1055-1060
48. Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, Nal B, Chu K, Kudelko M, Kam YW, Achdout H, Mandelboim M, Altmeyer R, Mandelboim O, Bruzzone R, Porgador A (2008) H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 82(4):2028-2032
49. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31(9):2680-2689
50. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7(5):517-523
51. Zhou G, Juang SW, Kane KP (2013) NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol 43(4):929-938
52. Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG, Chew MV, Chan T, Al-Garawi AA, Jordana M, Ashkar AA (2012) Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 206(2):167-177
53. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M, Levy E, Dusseaux M, Meyssonnier V, Premel V, Ngo C, Riteau B, Duban L, Robert D, Rottman M, Soudais C, Lantz O (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11(8):701-708
54. Garcia-Sastre A, Biron CA (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312(5775):879-882
55. Herold S, Ludwig S, Pleschka S, Wolff T (2012) Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol 92(1):75-82
56. Foucault ML, Moules V, Rosa-Calatrava M, Riteau B (2011) Role for proteases and HLA-G in the pathogenicity of influenza A viruses. J Clin Virol 51(3):155-159
57. Robb NC, Jackson D, Vreede FT, Fodor E (2010) Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein. J Gen Virol 91 (Pt 9):2331-2340
58. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252(2):324-330
59. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74(17):7989-7996
60. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74(24):11566-11573
61. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36(3):263-269
62. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A (2007) Inhibition of retinoic acidinducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81(2):514-524
63. Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81(13):7011-7021
64. Qiu Y, Krug RM (1994) The influenza virus NS1 protein is a poly (A)-binding protein that inhibits nuclear export of mRNAs containing poly (A). J Virol 68(4):2425-2432
65. Schultz-Cherry S, Dybdahl-Sissoko N, Neumann G, Kawaoka Y, Hinshaw VS (2001) Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol 75(17):7875-7881
66. Han X, Li Z, Chen H, Wang H, Mei L, Wu S, Zhang T, Liu B, Lin X (2012) Influenza virus A/Beijing/501/2009 (H1N1) NS1 interacts with beta-tubulin and induces disruption of the microtubule network and apoptosis on A549 cells. PLoS ONE 7(11):e48340
67. Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, Krug RM, Julkunen I (2007) Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 81(11):5995-6006
68. Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, Garcia-Sastre A, Palese P (2000) Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci USA 97(8):4309-4314
69. Conenello GM, Palese P (2007) Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe 2(4):207-209
70. Schmolke M, Manicassamy B, Pena L, Sutton T, Hai R, Varga ZT, Hale BG, Steel J, Perez DR, Garcia-Sastre A (2011) Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog 7(8):e1002186
71. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3(10):1414-1421
72. Zamarin D, Ortigoza MB, Palese P (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80(16):7976-7983
73. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, Palese P (2011) The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 7(6):e1002067
74. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1(1):e4
75. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7(12):1306-1312
76. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J (2004) PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 78(12):6304-6312
77. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2(4):240-249
78. Rouas-Freiss N, Khalil-Daher I, Riteau B, Menier C, Paul P, Dausset J, Carosella ED (1999) The immunotolerance role of HLA-G. Semin Cancer Biol 9(1):3-12
79. Menier C, Riteau B, Dausset J, Carosella ED, Rouas-Freiss N (2000) HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 61(11):1118-1125
80. Riteau B, Moreau P, Menier C, Khalil-Daher I, Khosrotehrani K, Bras-Goncalves R, Paul P, Dausset J, Rouas-Freiss N, Carosella ED (2001) Characterization of HLA-G1, -G2, -G3, and-G4 isoforms transfected in a human melanoma cell line. Transplant Proc 33(3):2360-2364
81. Khalil-Daher I, Riteau B, Menier C, Sedlik C, Paul P, Dausset J, Carosella ED, Rouas-Freiss N (1999) Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 43(2):175-182
82. Riteau B, Menier C, Khalil-Daher I, Martinozzi S, Pla M, Dausset J, Carosella ED, Rouas-Freiss N (2001) HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 13(2):193-201
83. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED (1999) HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43(2):203-211
84. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N (1999) HLAG-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11(8):1351-1356
85. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED (2001) HLA-G2, -G3, and-G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecific CTL cytolysis. J Immunol 166(8):5018-5026
86. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95(8):4510-4515
87. Adrian Cabestre F, Moreau P, Riteau B, Ibrahim EC, Le Danff C, Dausset J, Rouas-Freiss N, Carosella ED, Paul P (1999) HLA-G expression in human melanoma cells: protection from NK cytolysis. J Reprod Immunol 43(2):183-193
88. Riteau B, Faure F, Menier C, Viel S, Carosella ED, Amigorena S, Rouas-Freiss N (2003) Exosomes bearing HLA-G are released by melanoma cells. Hum Immunol 64(11):1064-1072
89. Menier C, Riteau B, Carosella ED, Rouas-Freiss N (2002) MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. Int J Cancer 100(1):63-70
90. Zilberman S, Schenowitz C, Agaugue S, Benoit F, Riteau B, Rouzier R, Carosella ED, Rouas-Freiss N, Menier C (2012) HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment. Eur J Immunol 42(6):1599-1608
91. Fainardi E, Castellazzi M, Stignani M, Morandi F, Sana G, Gonzalez R, Pistoia V, Baricordi OR, Sokal E, Pena J (2011) Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 68(3):433-451
92. Li C, Toth I, Schulze Zur Wiesch J, Pereyra F, Rychert J, Rosenberg ES, Van Lunzen J, Lichterfeld M, Yu XG (2013) Functional characterization of HLA-G (+) regulatory T cells in HIV-1 infection. PLoS Pathog 9(1):e1003140
93. Larsen MH, Zinyama R, Kallestrup P, Gerstoft J, Gomo E, Thorner LW, Berg TB, Erikstrup C, Ullum H (2013) HLA-G 3' untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population. J Infect Dis 207(6):903-906
94. Segat L, Catamo E, Fabris A, Morgutti M, D'Agaro P, Campello C, Crovella S (2010) HLA-G0105N allele is associated with augmented risk for HIV infection in white female patients. AIDS 24(12):1961-1964
95. Shi WW, Lin A, Xu DP, Bao WG, Zhang JG, Chen SY, Li J, Yan WH (2011) Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection. Hum Immunol 72(11):1068-1073
96. Le Bouder F, Khoufache K, Menier C, Mandouri Y, Keffous M, Lejal N, Krawice-Radanne I, Carosella ED, Rouas-Freiss N, Riteau B (2009) Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum Immunol 70(12):1016-1019
97. Chen HX, Chen BG, Shi WW, Zhen R, Xu DP, Lin A, Yan WH (2011) Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum Immunol 72(2):159-165
98. Tsotsiashvilli M, Levi R, Arnon R, Berke G (1998) Activation of influenza-specific memory cytotoxic T lymphocytes by Concanavalin A stimulation. Immunol Lett 60 (2-3):89-95
99. Li OT, Chan MC, Leung CS, Chan RW, Guan Y, Nicholls JM, Poon LL (2009) Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS ONE 4(5):e5658
100. Hu J, Hu Z, Song Q, Gu M, Liu X, Wang X, Hu S, Chen C, Liu H, Liu W, Chen S, Peng D, Liu X (2013) The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice. J Virol 87(5):2660-2672
101. Zeng H, Pappas C, Belser JA, Houser KV, Zhong W, Wadford DA, Stevens T, Balczon R, Katz JM, Tumpey TM (2012) Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. J Virol 86(2):667-678
102. Suguitan AL Jr, Matsuoka Y, Lau YF, Santos CP, Vogel L, Cheng LI, Orandle M, Subbarao K (2012) The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J Virol 86(5):2706-2714
103. Riteau B, De Vaureix C, Lefevre F (2006) Trypsin increases pseudorabies virus production through activation of the ERK signalling pathway. J Gen Virol 87 (Pt 5):1109-1112
104. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B (2013) PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 123(1):206-214
105. Feistritzer C, Riewald M (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105(8):3178-3184
106. Antoniak S, Owens AP 3rd, Baunacke M, Williams JC, Lee RD, Weithauser A, Sheridan PA, Malz R, Luyendyk JP, Esserman DA, Trejo J, Kirchhofer D, Blaxall BC, Pawlinski R, Beck MA, Rauch U, Mackman N (2013) PAR-1 contributes to the innate immune response during viral infection. J Clin Invest 123(3):1310-1322
107. Berri F, Rimmelzwaan GF, Hanss M, Albina E, Foucault-Grunenwald ML, Le VB, Vogelzang-van Trierum SE, Gil P, Camerer E, Martinez D, Lina B, Lijnen R, Carmeliet P, Riteau B (2013) Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog 9(3):e1003229
108. Aerts L, Hamelin MÈ, Rhéaume C, Lavigne S, Couture C, Kim W, Susan-Resiga D, Prat A, Seidah NG, Vergnolle N, Riteau B, Boivin G (2013) Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model. Plos One 8:e72529
109. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146(6):980-991
110. Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, Watanabe T, Hatta M, Shinya K, Suresh M, Kawaoka Y, Rosen H, Oldstone MB (2011) Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci USA 108(29):12018-12023
111. Marsolais D, Hahm B, Walsh KB, Edelmann KH, McGavern D, Hatta Y, Kawaoka Y, Rosen H, Oldstone MB (2009) A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci USA 106(5):1560-1565
112. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, Brass LF (2000) Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275(18):13502-13509
113. Khoufache K, Le Bouder F, Morello E, Laurent F, Riffault S, Andrade-Gordon P, Boullier S, Rousset P, Vergnolle N, Riteau B (2009) Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gammadependent pathway. J Immunol 182(12):7795-7802
114. Esmon CT (2012) Protein C anticoagulant system-anti-inflammatory effects. Semin Immunopathol 34(1):127-132
115. Schouten M, Sluijs KF, Gerlitz B, Grinnell BW, Roelofs JJ, Levi MM, Van't Veer C, Poll T (2010) Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study. Crit Care 14(2):R65
116. Schouten M, Van't Veer C, Levi M, Esmon CT, Van Der Poll T (2011) Endogenous protein C inhibits activation of coagulation and transiently lowers bacterial outgrowth in murine Escherichia coli peritonitis. J Thromb Haemost 9(5):1072-1075
117. Meilhac O, Ho-Tin-Noe B, Houard X, Philippe M, Michel JB, Angles-Cano E (2003) Pericellular plasmin induces smooth muscle cell anoikis. FASEB J 17(10):1301-1303
118. Degen JL, Bugge TH, Goguen JD (2007) Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 5 (Suppl 1):24-31
119. Goto H, Kawaoka Y (1998) A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci USA 95(17):10224-10228
120. Le Bouder F, Lina B, Rimmelzwaan GF, Riteau B (2010) Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J Gen Virol 91 (Pt 11):2753-2761
121. Goto H, Wells K, Takada A, Kawaoka Y (2001) Plasminogenbinding activity of neuraminidase determines the pathogenicity of influenza A virus. J Virol 75(19):9297-9301
122. Wang ZF, Su F, Lin XJ, Dai B, Kong LF, Zhao HW, Kang J (2011) Serum D-dimer changes and prognostic implication in 2009 novel influenza A (H1N1). Thromb Res 127(3):198-201
123. Soepandi PZ, Burhan E, Mangunnegoro H, Nawas A, Aditama TY, Partakusuma L, Isbaniah F, Ikhsan M, Swidarmoko B, Sutiyoso A, Malik S, Benamore R, Baird JK, Taylor WR (2010) Clinical course of avian influenza A (H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest 138(3):665-673
124. Mehta R, Shapiro AD (2008) Plasminogen deficiency. Haemophilia 14(6):1261-1268
125. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL (1996) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87(4):709-719
126. Gando S (2013) Role of fibrinolysis in sepsis. Semin Thromb Hemost 39(4):392-399